<h3><strong>Results</strong>: Analysis revealed a significant increase in controlled DM cases, rising from zero in 2019-2020 to 1,258 in 2022-2023, while uncontrolled cases decreased from five to 31. Enrollment trends showed a surge in previously enrolled cases from 162 to 2,875, with newly enrolled cases peaking at 464 in 2021-2022. Type II DM cases consistently exceeded Type I, peaking in 2021-2022. Males consistently outnumbered females, with the highest counts in 2023-2024 (2,169 males and 2,058 females). Notably, DM cases among patients under 40 years increased from 1,220 to 2,301, while cases for those aged 40 and older remained low.</h3>